Patrick B. Mark

16.9k total citations · 2 hit papers
250 papers, 6.3k citations indexed

About

Patrick B. Mark is a scholar working on Nephrology, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Patrick B. Mark has authored 250 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 98 papers in Nephrology, 80 papers in Cardiology and Cardiovascular Medicine and 56 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Patrick B. Mark's work include Dialysis and Renal Disease Management (51 papers), Chronic Kidney Disease and Diabetes (45 papers) and Diabetes Treatment and Management (28 papers). Patrick B. Mark is often cited by papers focused on Dialysis and Renal Disease Management (51 papers), Chronic Kidney Disease and Diabetes (45 papers) and Diabetes Treatment and Management (28 papers). Patrick B. Mark collaborates with scholars based in United Kingdom, United States and Netherlands. Patrick B. Mark's co-authors include Alan G. Jardine, Henry J. Dargie, Sokratis Stoumpos, Rajan K. Patel, Jennifer S. Lees, Paul Welsh, Giles Roditi, Tracey Steedman, Naveed Sattar and Kevin G. Blyth and has published in prestigious journals such as The Lancet, Circulation and Nature Medicine.

In The Last Decade

Patrick B. Mark

234 papers receiving 6.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prevalence, outcomes, and cost of chronic kidney disease in a contemporary population of 2·4 million patients from 11 countries: The CaReMe CKD study

2022 191 citations Patrick B. Mark, Manish M. Sood et al. profile →
Cardiovascular complications in chronic kidney disease: a review from the European Renal and Cardiovascular Medicine Working Group of the European Renal Association

2023 129 citations Patrick B. Mark, Christoph Wanner et al. profile →

Peers

Countries citing papers authored by Patrick B. Mark

Since Specialization

Citations

This map shows the geographic impact of Patrick B. Mark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick B. Mark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick B. Mark more than expected).

Fields of papers citing papers by Patrick B. Mark

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick B. Mark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick B. Mark. The network helps show where Patrick B. Mark may publish in the future.

Co-authorship network of co-authors of Patrick B. Mark

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick B. Mark. A scholar is included among the top collaborators of Patrick B. Mark based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick B. Mark. Patrick B. Mark is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Dickkopf-3 (DKK3) and the Progression of Diabetic Kidney Disease in Primary Health Care 2025 ·Diabetes ·(unknown), Stefan Schunk, (unknown), (unknown), (unknown), Susanne Eder, Johannes Leierer, Hiddo J.L. Heerspink, Patrick B. Mark, László Rosivall, Andrzej Więcek, Gert Mayer, Danilo Fliser	1
2	Urinary Clusterin is a Biomarker of Renal Epithelial Senescence and Predicts Human Kidney Disease Progression 2025 ·Kidney International Reports ·David Baird, (unknown), (unknown), Marie-Helena Docherty, (unknown), Thomas G. Mason, (unknown), Matthieu Vermeren, Andy Nam, (unknown), (unknown), Claire Williams, Jamie P. Traynor, Patrick B. Mark, Katie J. Mylonas, Jeremy Hughes, Laura Denby, Bryan R. Conway, David A. Ferenbach	2
3	Arteriovenous fistula for haemodialysis as a predictor of de novo heart failure in kidney transplant recipients 2024 ·Clinical Kidney Journal ·Sokratis Stoumpos, (unknown), Kenneth Mangion, Peter Thomson, Patrick B. Mark	2
4	Effect of empagliflozin on epicardial adipose tissue volume in patients with type 2 diabetes, or prediabetes, and heart failure with reduced ejection fraction (SUGAR-DM-HF) 2024 ·European Heart Journal ·(unknown), (unknown), Colin Berry, Ross T. Campbell, Kieran F. Docherty, John Dreisbach, Pardeep S. Jhund, Kenneth Mangion, Patrick B. Mark, John J.V. McMurray, Joanna Osmanska, Giles Roditi, Mark C. Petrie, (unknown), Matthew M.Y. Lee	2
5	Sodium zirconium cyclosilicate treatment and rates of emergency interventions for hyperkalaemia: a propensity–score weighted case–control study 2024 ·Clinical Kidney Journal ·(unknown), (unknown), Jamie P. Traynor, Keith Gillis, Patrick B. Mark, Jennifer S. Lees	0
6	Stopping Versus Continuing Metformin in Patients With Advanced CKD: A Nationwide Scottish Target Trial Emulation Study 2024 ·American Journal of Kidney Diseases ·(unknown), Edouard L. Fu, Stuart J. McGurnaghan, Bryan R. Conway, Neeraj Dhaun, (unknown), Ewan R. Pearson, Patrick B. Mark, John R. Petrie, Helen M. Colhoun, Samira Bell, Rory J. McCrimmon, Catherine Armstrong, Alistair Emslie‐Smith, Robert S. Lindsay, Sandra MacRury, John McKnight, Donald Pearson, Brian McKinstry	2
7	The impact of VEGF signalling pathway inhibitors and/or immune checkpoint inhibitors on kidney function over time: a single centre retrospective analysis 2024 ·SHILAP Revista de lepidopterología ·(unknown), Michael Sullivan, (unknown), Nicole De La Mata, Angela C Webster, Balaji Venugopal, Robert J. Jones, Ninian N. Lang, Patrick B. Mark, Jennifer S. Lees	0
8	Phenome-wide analysis reveals epistatic associations between APOL1 variants and chronic kidney disease and multiple other disorders 2024 ·EBioMedicine ·Walt E. Adamson, Harry Noyes, P. Johnson, Anneli Cooper, Darren G. Monckton, (unknown), (unknown), Michael Sullivan, Patrick B. Mark, Rulan S. Parekh, Annette MacLeod	1
9	Association of CA-125 with markers of congestion, and effect of empagliflozin on CA-125 in patients with type 2 diabetes, or prediabetes, and heart failure with reduced ejection fraction (SUGAR-DM-HF) 2023 ·European Heart Journal ·Matthew M.Y. Lee, Paul Welsh, Colin Berry, Katriona Brooksbank, Ross T. Campbell, Kieran F. Docherty, Joanna Osmanska, Giles Roditi, Kirsty Wetherall, Alex McConnachie, Patrick B. Mark, John J.V. McMurray, Pardeep S. Jhund, Mark C. Petrie, Naveed Sattar	0
10	Personalised lung cancer risk stratification and lung cancer screening: do general practice electronic medical records have a role? 2023 ·British Journal of Cancer ·Bhautesh Jani, Michael Sullivan, Peter Hanlon, Barbara I. Nicholl, Jennifer S. Lees, (unknown), Sara Macdonald, Patrick B. Mark, Frances S Mair, Frank Sullivan	2
11	Potential impact of NICE guidelines on referrals from primary care to nephrology: a primary care database and prospective research study 2022 ·British Journal of General Practice ·Michael Sullivan, Bhautesh Jani, Elaine Rutherford, Paul Welsh, Alex McConnachie, Rupert Major, David McAllister, Dorothea Nitsch, Frances S Mair, Patrick B. Mark, Jennifer S. Lees	10
12	Myocardial changes on 3T cardiovascular magnetic resonance imaging in response to haemodialysis with fluid removal 2021 ·Journal of Cardiovascular Magnetic Resonance ·Alastair J. Rankin, Kenneth Mangion, Jennifer S. Lees, Elaine Rutherford, Keith Gillis, (unknown), (unknown), Thomas A. Treibel, Aleksandra Radjenovic, Rajan K. Patel, Colin Berry, Giles Roditi, Patrick B. Mark	7
13	Image‐based computational fluid dynamics for estimating pressure drop and fractional flow reserve across iliac artery stenosis: A comparison with in‐vivo measurements 2021 ·International Journal for Numerical Methods in Biomedical Engineering ·(unknown), Pauline Hall Barrientos, (unknown), Aleksandra Radjenovic, Patrick B. Mark, Giles Roditi, Manosh C. Paul	5
14	Global longitudinal strain by feature-tracking cardiovascular magnetic resonance imaging predicts mortality in patients with end-stage kidney disease 2021 ·Clinical Kidney Journal ·Alastair J. Rankin, (unknown), Kenneth Mangion, Elaine Rutherford, Keith Gillis, Jennifer S. Lees, (unknown), Rajan K. Patel, Colin Berry, Giles Roditi, Patrick B. Mark	5
15	Lipoprotein(a) and cardiovascular disease: prediction, attributable risk fraction and estimating benefits from novel interventions 2020 ·European Heart Journal ·Paul Welsh, Claire Welsh, Carlos Celis‐Morales, Rosemary Brown, Lyn D Ferguson, Stuart R. Gray, Patrick B. Mark, Jim Lewsey, Donald M. Lyall, Jason M. R. Gill, Jill P. Pell, Pardeep S. Jhund, James A. de Lemos, Peter Willeit, Naveed Sattar	6
16	Ferumoxytol MR Angiography versus Duplex US for Vascular Mapping before Arteriovenous Fistula Surgery for Hemodialysis 2020 ·Radiology ·Sokratis Stoumpos, (unknown), Pauline Hall Barrientos, Karen Stevenson, Peter Thomson, Ram Kasthuri, Aleksandra Radjenovic, David Kingsmore, Giles Roditi, Patrick B. Mark	18
17	Benefits and Harms of Oral Anticoagulant Therapy in Chronic Kidney Disease 2019 ·Annals of Internal Medicine ·Jeffrey T. Ha, Brendon L. Neuen, (unknown), Min Jun, Tadashi Toyama, Martin Gallagher, Meg Jardine, Manish M. Sood, Amit X. Garg, Suetonia C. Palmer, Patrick B. Mark, David C. Wheeler, Vivekanand Jha, Ben Freedman, David W. Johnson, Vlado Perkovic, Sunil V. Badve	3
18	Predicting outcome in acute interstitial nephritis: a case–series examining the importance of histological parameters 2019 ·Histopathology ·Alastair J. Rankin, Emma Cannon, Keith Gillis, (unknown), Patrick B. Mark, Colin Geddes, J. G. Fox, Bruce Mackinnon, Emily P. McQuarrie, David Kipgen	3
19	Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials 2016 ·The Lancet Diabetes & Endocrinology ·(unknown), William G. Herrington, Jonathan Emberson, Borislava Mihaylova, Lisa Blackwell, Christina Reith, Marit D. Solbu, Patrick B. Mark, Bengt Fellström, Alan G. Jardine, Christoph Wanner, Hallvard Holdaas, Jordan Fulcher, Richard Haynes, Martin Landray, Anthony Keech, John Simes, Rory Collins	203
20	Hyperresponders vs. nonresponder patients after renal denervation 2014 ·Journal of Hypertension ·Alexandre Persu, Michel Azizi, Yu Jin, Sebastian Völz, J. Rosa, Fadl Elmula M. Fadl Elmula, Antoinette Péchère-Bertschi, Michel Burnier, Patrick B. Mark, Arif Elvan, Jean Renkin, Marc Sapoval, Thomas Kahan, Sverre E. Kjeldsen, Jan A. Staessen	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact